#marijuana rescheduling

The industry looks back wistfully on a past year of promise but little delivery, and wonders what next under Trump For those awaiting the end of cannabis prohibition in the US, 2024 began on a hopeful note, but as the year comes to a close, many of those hopes remain unfulfilled. “The big issue is rescheduling, and there was a lot of excitement about that, but it’s been sort of mired down,” said…

The Drug Enforcement Administration has scheduled a hearing on the Biden administration’s proposal to reclassify marijuana under federal drug laws, effectively delaying the decision until after the November election. The agency scheduled a hearing on the proposed rule change for December 2, according to a report from cannabis news outlet Marijuana Moment. The proposed rule is the result of a…

Republicans are making a last push against the finalization of the Biden administration’s move to reschedule marijuana, despite advocates saying the fight isn’t worth the effort. The White House in May began the formal rulemaking process to move marijuana from Schedule I of the Controlled Substances Act (CSA) — drugs considered to have the highest potential for abuse, with no accepted medical use…

The Compassionate Care Act passed the North Carolina Senate for the third time in three years. It would provide for the sale of cannabis and cannabis-infused products to qualified patients with a debilitating medical condition through a regulated medical cannabis supply system. However, the bill continues to stall in the House. In addition, a recent Supreme Court ruling is impacting the path to…

Nebraska Attorney General Mike Hilgers sent a letter this week from 11 red states arguing that the Biden administration should not reclassify marijuana from a Schedule I drug to the lesser classification of Schedule III. The attorneys general from Alabama, Arkansas, Indiana, Iowa, Kansas, Louisiana, Mississippi, Montana, South Carolina and South Dakota joined Hilgers’ argument that the…

The Biden administration’s push to reclassify marijuana as a less dangerous drug won an endorsement Wednesday from Kentucky Gov. Andy Beshear, who said “the jury is no longer out” on its medical uses as an alternative to opioids that ravaged the Bluegrass State with overdose deaths. The Democratic governor called the proposal a “significant, common-sense step forward,” especially for people with…

By Vince Sliwoski, Managing Partner, Harris Sliwoski In case you haven’t heard, the Drug Enforcement Administration (DEA) wants to hear from you on marijuana rescheduling. Specifically, DEA invites your comments on its notice of proposed rulemaking (NPRM) to move both marijuana and marijuana extract from schedule I to schedule III of the federal Controlled Substances Act (CSA). The comment…

The House Appropriations Committee on Tuesday approved legislation to block the Biden administration’s ongoing efforts to reschedule marijuana and ease restrictions on the drug under federal law. The Republican-led panel approved an amendment to a funding bill that blocks the Department of Justice from acting on the rescheduling plan, which is currently in the midst of a rulemaking process to…